Skip to content
Screener

Incyte INCY Prepaid & Other Current

Prepaid & Other Current at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.22B-22.8%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$7.11M-60.4%
Gilead Sciences logo
Gilead SciencesGILD
$3.76B+29.7%
Geron logo
GeronGERN
$6.5M-10.5%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$7.79M-10.4%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$16.1M+90.3%

Other financials

Income statement

See full
Revenue$1.7B+37.7%
Gross profit$1.6B+38.0%
Operating income$697.9M+31.6%
Net income$585.6M+44.6%
EPS (diluted)$2.81+37.7%

Balance sheet

See full
Cash & equivalents$4.0B+104%
Total debt$38.3M-9.8%
Total equity$6.3B+52.1%
Total assets$7.9B+35.2%

Cash flow

See full
Operating cash flow$507.7M+1,035%
CapEx$1.6M-43.5%
Free cash flow$509.3M+1,069%

Valuation

See full
Market cap$24.28B+60.1%
Enterprise value$20.34B+53.5%
P/E15.1×-2.4×
P/S4.2×+0.9×

Profitability

See full
Gross margin92.6%-0.3pp
Operating margin30.6%+4.8pp
Net margin27.7%+8.7pp
FCF margin34%+12.3pp

Returns & leverage

See full
Return on equity30.7%+6.4pp
Debt / equity0.0×
Current ratio4.6×+1.7×

Where this comes from

Reported directly by Incyte in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Incyte’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000879169-26-000056
Line itemJune 30,2026December 31,2025*
Marketable securities—available-for-sale (amortized cost $555,856 and $480,793 as of June 30, 2026 and December 31, 2025, respectively; allowance for credit losses $0 as of June 30, 2026 and December 31, 2025)553,365482,787
Accounts receivable1,125,2031,024,407
Inventory112,542101,060
Prepaid expenses and other current assets253,087317,831
Total current assets6,026,5725,023,902
Restricted cash1,8161,852
Long term equity investments104,38747,991
Inventory345,026342,232

Item 1. Financial Statements

FAQ

What is Incyte's prepaid & other current?
Incyte (INCY) reported prepaid & other current of $253.09M in Q2 2026.
How has Incyte's prepaid & other current changed year-over-year?
Incyte's prepaid & other current decreased by 14.4% year-over-year, from $295.65M to $253.09M.
What is the long-term trend for Incyte's prepaid & other current?
Over 5 years (2020 to 2025), Incyte's prepaid & other current has grown at a 39.5% compound annual growth rate (CAGR), from $60.1M to $317.83M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Incyte's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude